• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Human Infection with Highly Pathogenic Avian Influenza A(H7N9) Virus, China

tetano

Editor, Senior Moderator
Emerg Infect Dis. 2017 Jul 17;23(8). doi: 10.3201/eid2308.170600. [Epub ahead of print]
[h=1]Human Infection with Highly Pathogenic Avian Influenza A(H7N9) Virus, China.[/h] Ke C, Mok CKP, Zhu W, Zhou H, He J, Guan W, Wu J, Song W, Wang D, Liu J, Lin Q, Chu DKW, Yang L, Zhong N, Yang Z, Shu Y, Peiris JSM.
[h=3]Abstract[/h] The recent increase in zoonotic avian influenza A(H7N9) disease in China is a cause of public health concern. Most of the A(H7N9) viruses previously reported have been of low pathogenicity. We report the fatal case of a patient in China who was infected with an A(H7N9) virus having a polybasic amino acid sequence at its hemagglutinin cleavage site (PEVPKRKRTAR/GL), a sequence suggestive of high pathogenicity in birds. Its neuraminidase also had R292K, an amino acid change known to be associated with neuraminidase inhibitor resistance. Both of these molecular features might have contributed to the patient's adverse clinical outcome. The patient had a history of exposure to sick and dying poultry, and his close contacts had no evidence of A(H7N9) disease, suggesting human-to-human transmission did not occur. Enhanced surveillance is needed to determine whether this highly pathogenic avian influenza A(H7N9) virus will continue to spread.


[h=4]KEYWORDS:[/h] CMV reactivation; China; H7N9; HPAI; R292K mutation; acute respiratory distress syndrome; antimicrobial resistance; chickens; hemagglutinin; highly pathogenic avian influenza; hypoxia; influenza; neuraminidase; oseltamivir resistance; poultry; viral pneumonia; zoonoses

PMID: 28580899 DOI: 10.3201/eid2308.170600
 
Back
Top Bottom